AGX Genome is a global life-and-health research group — a pioneer in precision medical nutrition. We exist to push the limits of what life can be, and to make precision intervention a deliverable reality rather than a concept.
Founded in 1989 in Houston, we built our science on three engines: genomics tells you who you are, cell technology tells you how you are now, and our AIVC™ virtual cell tells our researchers what will actually work for you — a closed loop where every formula is validated in simulation before it enters your life.
Meet our team →
We publish every test result, every sourcing decision, every clinical citation. If we can't back a claim with published data, we don't make the claim.
Our marine ingredients are sourced under the strictest environmental protocols. We fund independent population surveys and publish our sustainability audits annually.
Every formulation begins in peer-reviewed literature, not market research. We hire scientists first, marketers second — and our packaging reflects the difference.
Our paediatric formulations are designed with pharmacists and paediatricians. Growing children deserve the same rigour as clinical-grade adult supplements.
A compound is only as valuable as what the body absorbs. We use triglyceride-form omega-3s, liquid calcium, and food-matrix phospholipids because the evidence demands it.
We don't chase trends. Omega-3 research spans 40 years of consistent evidence. We build on foundations — not fashion.
AGX Genome is established in Houston by a team of clinical-nutrition, multi-omics, cell-biology, genomics, systems-medicine and AI scientists — with a single conviction: every intervention should begin with a deep understanding of the individual.
A pharmaceutical-grade softgel production base comes online, anchoring AGX's vertically-integrated, own-factory manufacturing model.
Houston (US) for strategy & AIVC, Germany (DE) for anti-cancer medical nutrition, Toronto (CA) for foundational life-science research, and Auckland (NZ) for applied marine & deer-placenta science.
AGX formalises its dual engine — advanced life science plus AI — pairing the AIVC™ virtual cell with genomics and cell technology across every product line.
AGX products and precision-nutrition protocols now serve more than 250,000 families across 15+ countries, with a 98% would-recommend rate.

MD, PhD in Marine Biochemistry (UBC). 18 years researching omega-3 lipid biochemistry. Author of 34 peer-reviewed papers on DPA metabolism and cardiovascular outcomes.

PhD in Marine Biology (NUS). Led Greenland Arctic expeditions 2010–2015. Expert in sustainable marine harvesting protocols and Arctic ecosystem management.

MD, Paediatrics (University of Toronto). Specialised in infant and child nutritional supplementation. Clinical advisor to Wellborn and Mickey Health product lines.

PhD in Gerontology (Keio University). Director of longevity research at NTU Singapore. Advisory role across all anti-ageing formulation development.